Shelton Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Buy
1,361
+198
+17% +$202K 0.64% 47
2026
Q1
$1.07M Sell
1,163
-176
-13% -$178K 0.47% 73
2025
Q4
$1.44M Buy
1,339
+68
+5% +$65K 0.62% 47
2025
Q3
$970K Buy
1,271
+77
+6% +$57.3K 0.44% 79
2025
Q2
$931K Sell
1,194
-16
-1% -$12.4K 0.45% 79
2025
Q1
$999K Buy
1,210
+55
+5% +$45.8K 0.54% 61
2024
Q4
$892K Buy
1,155
+422
+58% +$349K 0.46% 78
2024
Q3
$649K Buy
733
+89
+14% +$80K 0.35% 89
2024
Q2
$583K Buy
644
+73
+13% +$58.4K 0.33% 89
2024
Q1
$444K Buy
571
+50
+10% +$35.6K 0.28% 84
2023
Q4
$304K Buy
+521
New +$304K 0.22% 85

Other funds holding LLY

Shelton Wealth Management's LLY Position: Q2 2026 in Review

Shelton Wealth Management increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $202K and bringing the position to 1,361 shares worth $1.63M. The position accounts for 0.64% of the portfolio, ranked #47.

Shelton Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 866 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Shelton Wealth Management held 1,361 shares of Eli Lilly worth $1.63M as of Q2 2026.
  • Shelton Wealth Management bought 198 Eli Lilly shares in Q2 2026, an estimated $202K.
  • Eli Lilly made up 0.64% of Shelton Wealth Management's portfolio in Q2 2026, its #47 holding.
  • Shelton Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 866 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Shelton Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.